Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis

Hepatology

Volumn 26, Issue 4, 1997, Pages 858-864

  Woitas, Rainer P ^a,b   Heller, Jörg ^a   Stoffel Wagner, Birgit ^a   Spengler, Ulrich ^a   Sauerbruch, Tilman ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Allgemeine Innere Medizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ALDOSTERONE; AMINO ACID; CYCLIC GMP; INULIN; NITRATE; NITRIC OXIDE; NITRITE; RENIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNORADIOMETRIC ASSAY; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; PLASMA; PORTAL HYPERTENSION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SPECTROPHOTOMETRY; URINE;

EID: 0030864821     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260409     Document Type: Article

References (63)

1. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776-778.
2. Arroyo V, Gines P. Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis. Gastroenterology 1992;102:1077-1157.
3. Schrier RW, Niederberger M. Paradoxes of body fluid volume regulation in health and disease. A unifying hypothesis. West J Med 1994;161: 393-408.
4. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. HEPATOLOGY 1988;8: 1151-1157.
5. Lang F, Ottl I, Häussinger D, Deetjen P, Ahloulay M, Bankir L. Renal hemodynamic response to intravenous and oral amino acids in animals. Semin Nephrol 1995;15:415-418.
6. terWee PM. Renal effects of intravenous amino acid administration in humans with and without renal disease: hormonal correlates. Semin Nephrol 1995;15:426-432.
7. Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 1994;46:230-236.
8. King AJ. Nitric oxide and the renal hemodynamic response to proteins. Semin Nephrol 1995;15:405-414.
9. Wong F, Massie D, Colman J, Dudley F. Glomerular hyperfiltration in patients with well-compensated alcoholic cirrhosis. Gastroenterology 1993;104:884-889.
10. terWee PM, Tegzess AM, Donker AJ. Pair-tested renal reserve filtration capacity in kidney recipients and their donors. J Am Soc Nephrol 1994; 4:1798-1808.
11. Böhler J, Woitas R, Keller E, Reetze Bonorden P, Schollmeyer PJ. Effect of nifedipine and captopril on glomerular hyperfiltration in normotensive man. Am J Kidney Dis 1992;20:132-139.
12. Tack I, Rostaing L, Tran VT, Lloveras JJ, Durand D, Suc JM, Ader JL. Renal functional reserve in calcium channel blocker-treated hypertensive recipients of kidney transplant. Nephrol Dial Transplant 1995;6: 117-119.
13. Isakson B. Urinary nitrogen output is a valid test in dietary surveys. Am J Clin Nutr 1980;33:4-12.
14. terWee PM, van Ballegooie E, Rosman JB, Meijer S, Donker AJ. Renal reserve filtration capacity in patients with type 1 (insulin-dependent) diabetes mellitus. Nephrol Dial Transplant 1987;2:504-509.
15. terWee PM, Tegzess AM, Donker AJ. Renal reserve filtration capacity before and after kidney donation. J Intern Med 1990;228:393-399.
16. Claris-Appiani A, Assael BM, Tirelli AS, Cavanna G, Marra G. Sodium excretion and hyperfiltration during glucose infusion in man. Am J Nephrol 1990;10:103-108.
17. Böhler J, Becker A, Reetze Bonorden P, Woitas R, Keller E, Schollmeyer P. Effect of antihypertensive drugs on glomerular hyperfiltration and renal haemodynamics. Comparison of captopril with nifedipine, metoprolol and celiprolol. Eur J Clin Pharmacol 1993;44(Suppl 1):57-61.
18. Maddox DA, Brenner BM. Glomerular ultrafiltration. In: Brenner BM RF, ed. The Kidney. Philadelphia: Saunders, 1991:205-244.
19. Green GL, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum S. Analysis of nitrate, nitrite and 15 N-nitrite in biological fluids. Anal Biochem 1982;126:131-138.
20. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, Mourelle M, Moncada S. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. HEPATOLOGY 1993;18:1139-1143.
21. Griess P. Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt "Über einige Azoverbindungen". Ber Dtsch Chem Ges 1879; 1:426-428.
22. Davidson WD, Sackner MA. Simplification of the anthrone method for the determination of inulin in clearance studies. J Lab Clin Med 1962; 62:351-356.
23. Bratton EC, Marshall EK. A new coupling reagent for sulfanilamide determination. J Biol Chem 1938;128:537-550.
24. Curtis JJ, Luke R, Dubowsky E, Diethelm AG, Whelchel JD, Jones P. Cyclosporine in therapeutic doses increases renal allograft vascular resistance. Lancet 1986;2(8505):477-479.
25. DeSanto NG, Anastasio P, Loguercio C, del Vecchio Blanco C, Capasso G, Coppola S, Bellini L, et al. Glucagon-independent renal hyperaemia and hyperfiltration after an oral protein load in Child A liver cirrhosis. Eur J Clin Invest 1992;22:31-37.
26. DeSanto NG, Anastasio P, Loguercio C, Spitali L, Del Vecchio Blanco C, Corvinelli M, Girillo M. Creatinine clearance: an inadequate marker of renal filtration in patients with early posthepatitic cirrhosis (Child A) without fluid retention and muscle wasting. Nephron 1995;70:421-424.
27. Wong F, Massie D, Hsu P, Dudley F. Dose-dependent effects of oral misoprostol on renal function in alcoholic cirrhosis. Gastroenterology 1994;106:658-663.
28. Wong F, Massie D, Hsu P, Dudley F. The dose-dependent effect of misoprostol on indomethacin-induced renal dysfunction in well compensated cirrhosis. Am J Gastroenterol 1995;90:1465-1470.
29. Wong F, Massie D, Hsu P, Dudley F. Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis. Gastroenterology 1993;104:869-876.
30. Baumann JE, Persson PB, Ehmke H, Nafz B, Kirchheim HR. Role of endothelium-derived relaxing factor in renal autoregulation in conscious dogs. Am J Physiol 1992;263:F208-F213.
31. Ohishi K, Carmines PK, Inscho EW, Navar LG. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am J Physiol 1992;263:F900-F906.
32. Jimenez W, Rodes J. Impaired responsiveness to endogenous vasoconstrictors and endothelium-derived vasoactive factors in cirrhosis. Gastroenterology 1994;107:1201-1203.
33. Krishna GG, Newell G, Miller E, Heeger P, Smith R, Polansky M, Kapoor S, et al. Protein-induced glomerular hyperfiltration: role of hormonal factors. Kidney Int 1988;33:578-583.
34. Moreau R, Soubrane O, Sogni P, Hadengue A, Gaudin C, Lin HC, Pussard E, et al. Hemodynamic, neurohumoral, and metabolic responses to amino acid infusion in patients with cirrhosis. Gastroenterology 1992;103:601-608.
35. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver diease and the hepatorenal syndrome. N Engl J Med 1992;327:1774-1778.
36. Moore K, Ward PS, Taylor GW, Williams R. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology 1991;100:1069-1077.
37. terWee PM, Geerlings W, Rosman JB, Sluiter WJ, van der Geest S, Donker AJM. Testing renal reserve filtration with an amino acid solution. Nephron 1985;41:193-199.
38. Bosch JP. Renal reserve: a functional view of glomerular filtration rate. Semin Nephrol 1995;15:381-385.
39. Woods LL. Mechanisms of renal hemodynamic regulation in response to protein feeding. Kidney Int 1993;44:659-675.
40. Wada L, Don BR, Schambelan M. Hormonal mediators of amino acid-induced glomerular hyperfiltration in humans. Am J Physiol 1991;260: F787-792.
41. Ruilope LM, Lahera V, Rodicio JL, Romero JC. Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens 1994;12:625-631.
42. Tajiri K, Miyakawa H, Izumi N, Marumo F, Sato C. Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide. HEPATOLOGY 1995;22:1430-1435.
43. Bank N, Aynedjian HS. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993;43:1306-1312.
44. Abrams GA, Trauner M, Nathanson MH. Nitric oxide and liver disease. Gastroenterologist 1995;3:220-233.
45. Atucha NM, Garcia Estan J, Ramirez A, Perez MC, Quesada T, Romero JC. Renal effects of nitric oxide synthesis inhibition in cirrhotic rats. Am J Physiol 1994;267:R1454-1460.
46. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 1994;24:112-129.
47. Baylis C. Glomerular filtration and volume regulation in gravid animal models. Baillieres Clin Obstet Gynaecol 1994;8:235-264.
48. Tolins JP, Shultz PJ, Westberg G, Raij L. Renal hemodynamic effects of dietary protein in the rat: role of nitric oxide. J Lab Clin Med 1995; 125:228-236.
49. Baylis C, Harvey J, Engels K. Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotension II. J Am Soc Nephrol 1994; 5:211-214.
50. Niederberger M, Martin PY, Gines P, Morris K, Tsai P, Xu DL, McMurtry I, et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 1995;109:1624-1630.
51. Niederberger M, Gines P, Tsai P, Martin PY, Morris K, Weigert A, McMurtry I, et al. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis. HEPATOLOGY 1995;21:1625-1631.
52. Niederberger M, Gines P, Martin PY, Tsai P, Morris K, McMurtry I, Schrier RW. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. HEPATOLOGY 1996;24:947-951.
53. Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992;103:1928-1949.
54. Sogni P, Moreau R, Ohsuga M, Cailmail S, Oberti F, Hadengue A, Pussard E, et al. Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis. HEPATOLOGY 1992;16:980-983.
55. Green I, Hiatt EP. Behaviour of the nitrate ion in the dog. Am J Physiol 1953;176:463-467.
56. Green I, Hiatt EP. Renal excretion of nitrate and its effect on excretion of sodium and chloride. Am J Physiol 1954;180:179-182.
57. Saul RL, Kabir SH, KS Cohen Z, Bruce WR, Archer MC. Reevaluation of nitrate and nitrite levels in the human intestine. Cancer Res 1981; 41:2280-2283.
58. Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, Kaminiski PM, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 1995;91:2982-2988.
59. Campillo B, Bories PN, Benvenuti C, Dupeyron C. Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation. J Hepatol 1996;4:707-714.
60. Suto T, Losonczy G, Qiu C, Hill C, Samsell L, Ruby J, Charon N, et al. Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int 1995; 48:1272-1277.
61. Raij L, Shultz PJ. Endothelium-derived relaxing factor, nitric oxide: effects on and production by mesangial cells and the glomerulus. J Am Soc Nephrol 1993;3:1435-1441.
62. Raij L, Baylis C. Glomerular actions of nitric oxide. Kidney Int 1995; 48:20-32.
63. Shultz PJ, Tayeh MA, Marietta MA, Raij L. Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am J Physiol 1991;261:F600-606.